Latin American consensus on psoriasis severity classification.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Londoño-García Angela María, Castro-Ayarza Juan Raúl, Franco Franco Manuel Darío, Ardila Cesar Fernando González, Magariños Gabriel, Zaldívar Enrique Salvador Rivas, Martínez Susan, Ibatá Linda, Castillo Julieth Carolina, Rojas Paola Jimena Cárdenas, Vargas Evelyn Giuliana Castro, Contreras Claudia Romina, Correa Carolina Ivette Cortes, Fernández Claudia de la Cruz, Restrepo Andrés Chavarriaga, Echeverria Cristina Mariela, Carvalho André Vicente Esteves de, Hidalgo Matlock Benjamín, Loayza Enrique, Maskin Matías Rafael, Romiti Ricardo, Valenzuela Fernando
Аннотация
OBJECTIVE: To present a consensus of experts in Latin America regarding the classification of psoriasis severity, based on the best available evidence and applicable to current medical practice in the region.
METHODS: An independent methodological team, together with a group of clinical dermatologists representatives from different Latin American countries, developed a consensus with a modified Delphi methodology based on a systematic review of the literature. This consensus includes the classification of psoriasis, tools to define the severity of psoriasis, and other considerations in evaluating patients with psoriasis.
RESULTS: Fifteen statements were formulated aimed at classifying the severity of cutaneous psoriasis and other forms of the disease, as well as tools to assess and define the severity of psoriasis and therapy considerations. Additionally, the consensus addresses implementation considerations.
CONCLUSION: The results of this consensus constitute a solid basis for a standard classification terminology for the varied clinical forms of psoriasis and their therapeutic implications. The importance of maintaining a personalized therapeutic approach, adjusted to each country's available resources and administrative realities, is highlighted.